Objective To clarify the efficacy and safety of therapeutic endoscopic retrograde cholangiopancreatography for the elderly with choledocholithiasis compared with younger patients. Methods Consecutive therapeutic ERCPs performed between 2005 and 2007 at our institution for 118 patients aged 80 years or older (group A) and 205 patients younger than 80 years old (group B) were retrospectively reviewed. Successful cannulation rate, complete stone clearance rate, complications and prognosis were compared between the two groups. Results Successful cannulation was achieved in 99.2% in group A versus 99.5% in group B. The complete stone clearance rate was significantly lower in group A than in group B (92.4% versus 99.0%, p<0.01). Plastic stent placement was performed for patients with incomplete duct clearance. There was no significant difference in the early complication rate between group A (5.5%) and group B (6.6%). Procedure-related mortality did not occur. Cholangitis-free survival was similar between the two groups. The short-term prognosis was comparable between those with complete duct clearance and those with biliary stent placement. Conclusion With a duct clearance rate of more than 90% and plastic stent placement for patients with poor general condition, therapeutic ERCP for choledocholithiasis in patients 80 years of age or older is comparable in safety and effectiveness to that in younger patients.
Introduction
With the global prolongation of life expectancy, the number of elderly patients with choledocholithiasis is increasing (1-3). The prevalence of gallbladder and bile duct stones rises with age (3) (4) (5) , and postoperative morbidity and mortality increase with age and presence of concomitant diseases. In patients 80 years of age or older with choledocholithiasis, the mortality rate of common bile duct exploration is significantly higher than in younger patients (1) . Endoscopic retrograde cholangiopancreatography (ERCP) has been recognized as a treatment with less risk and lower mortality than surgery (6) . Although biliary stent placement could be an alternative for complete duct clearance in highrisk patients, the long-term outcome remains a matter of concern (7-10). Higher periprocedural complications and lower complete duct clearance rates might be expected in elderly patients because of the high prevalence of poor general condition. Although previous studies suggest that therapeutic ERCP is safe and effective for the elderly (11) (12) (13) (14) , the numbers of large comparative studies are still limited. In this study, we aimed to retrospectively evaluate the safety and short-term outcome of therapeutic ERCP in a large population aged 80 or older compared with those in a younger age group. ERCPs were performed by experienced endoscopists and trainees under the supervision of experts. Standard duodenoscopes (JF-V260, TJF-230, Olympus Co, Tokyo, Japan) were used for the procedures. An anterior oblique-viewing endoscope (XK-240, Olympus Co.) was used for patients with prior Billroth-II gastrectomy. Endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilation (EPBD) was performed to facilitate stone removal in most cases. For stone removal, standard techniques (used basket, mechanical lithotripsy, balloon catheter) were applied. Electrohydraulic lithotripsy (EHL) was carried out for hard stones which were difficult to crush by mechanical lithotripsy (ML). Essentially, complete duct clearance was attempted at the time of each procedure. Performance of repeat endoscopy was determined based on discussion with the patient considering the information on the stability of his/her general condition during the previous procedure and the likelihood of complete duct clearance. When complete stone extraction was not achieved, a 7.2 Fr. or 8.0 Fr. double-pigtail catheter (ERBD-RP-72-110-SH10 or ERBD-RP-80-110-SH10, Hanaco Medical Co, Saitama, Japan) was positioned for bile duct drainage. Stent exchange (using one 7.2 Fr or 8.0 Fr double-pigtail catheter as mentioned above) was performed only when acute cholangitis recurred. Pentazocine and diazepam and/or midazolam were administered intravenously for conscious sedation under monitoring of peripheral oxygen saturation and blood pressure throughout the procedure. The initial dosages were 15 mg, 3-5 mg, and 2-3 mg, respectively, and titrated according to the response of patients. Oxygen supplementation through nasal cannulae was used as necessary. Vital signs, dosages of sedatives, and the responses of patients were recorded in detail by nurses during the procedure. Nafamostat mesilate was used to prevent post-ERCP pancreatitis for all patients for two days. Blood samples were routinely taken from all patients within several days before and the next day after ERCP.
Patients and Methods
Clinical features (Eastern Cooperative Oncology Group (ECOG) performance status scale, physical status classification of the American Society of Anesthesiologists (ASA), diameter and number of the stones, diameter of the bile duct, presence of periampullary diverticula) were reviewed from medical charts and films. Difficult bile duct cannulation was defined as the necessity of at least one of the following techniques for deep cannulation: pancreatic guidewire placement, precut, 2 devices-in-1-channel method, or rendezvous technique (which makes biliary cannulation possible using the guidewire antegradely passed into the duodenum through percutaneous transhepatic biliary drainage route). Cardiorespiratory suppression was defined as peripheral oxygen saturation <90% and/or systolic blood pressure <90 mmHg observed at any time during the procedure. Post-ERCP pancreatitis and its severity were decided according to the 1991 consensus guidelines by Cotton et al (15) with slight modification. Post-ERCP pancreatitis was defined as the onset of new abdominal pain, with at least a 3-fold elevation of the serum amylase level at more than 24 hours after the procedure. The severity of pancreatitis was defined based on the days of fasting required for recovery: mild, 2 to 3 days; moderate, 4-10 days; and severe, more than 10 days. Immediate postsphincterotomy bleeding was defined as hemorrhage which required endoscopic hemostasis [injection of hypertonic saline and epinephrine solution (HSE)], and delayed postsphincterotomy bleeding as manifested by melena at more than 24 hours afrer the procedure which necessitated endoscopic hemostasis. Recurrences of cholangitis were investigated by medical chart review or phone calls.
All statistical analyses were performed with StatMate (ATMS Co. Ltd., Tokyo, Japan). Data are expressed as mean ± SD. For categorical data, the χ 2 test or Fisher's exact probability test was used. For continuous variables, Student's t-test was used. The Kaplan-Meier method was applied for the estimation of the recurrence rate of cholangitis or cholecystitis, and compared by the log-rank test between the groups. A p value less than 0.05 was considered significant.
Results
Patient characteristics of the two groups are shown in Table 1. The proportion of females was significantly higher in group A (54%, p<0.01). The frequency of periampullary diverticulum, past history of cholecystectomy, the presence of concomitant gallbladder stones, and serum total bilirubin levels were not significantly different between the groups. The diameters of bile ducts and stones were significantly larger in group A (p<0.001). The mean number of stones and endoscopic procedures per patient were similar.
The performance status (PS) and ASA physical status of the patients are shown in Table 2 . The proportion of patients with PS 3 or 4 was significantly higher in group A (24%, p<0.001). There was no significant difference in ASA physical status between the groups. The proportion of patients with comorbidities was significantly higher in group A (p< 0.001), dementia being significantly more frequent in group A (p<0.001).
Deep cannulation of the bile duct was successful in 99.2% (117/118) in group A and 99.5% (204/205) in group B (p=0.692). In unsuccessful cases, the rendezvous method was applied which enabled the transpapillary approach. After all, all cases were treated via the transpapillary approach. T a b l e 1 . P a t i e n t Ch a r a c t e r i s t i c s T a b l e 3 . Re a s o n s f o r P e r ma n e n t P l a s t i c S t e n t P l a c e me n t 
T a b l e 2 . P a t i e n t s ' P S , AS A S t a t u s a n d Co mo r b i d i t i e s

T a b l e 4 . S e d a t i o n a n d P e r i p r o c e d u r a l E v e n t s T a b l e 5 . E a r l y Co mp l i c a t i o n s
The proportion of difficult cannulation cases was 8.5% (10/118) in group A and 5.9% (12/205) in group B, i.e. there was no significant difference between the two groups (p=0.368). In group A, EST and EPBD were performed in 109 and 3 cases, respectively. In group B, the numbers were 197 and 4. EPBD was chosen for patients who had undergone Billroth II reconstruction following distal gastrectomy or those under anticoagulant therapy. Complete stone clearance was achieved in 92.4% (109/118) of the patients in group A and in 99.0% (203/205) of those in group B, the rate being significantly lower in the former (p<0.01).
The reasons for permanent plastic stent placement are shown in Table 3 . Poor general condition was the most frequent reason, followed by a past history of distal gastrectomy with Billroth II reconstruction, the presence of large or hard stones which were difficult to crush by ML and likely to require several sessions to be removed, and confluence stones which were located at the hepatocholedochal junction and could not be caught by basket catheters.
Sedation and periprocedural events are presented in Table 4. There was no significant difference in procedure time between the groups. The total dosages of pentazocine and diazepam were significantly less in group A (p<0.01 and p< 0.001, respectively). Transient cardiorespiratory suppression was experienced in 13% (21/164) and 10% (27/266) of the cases (p=0.396) in groups A and B, respectively. None of these patients had to be mask-ventilated or intubated. Patient movement during the procedures was observed in 23% (38/ 164) in group A and in 6.0% (16/266) in group B (p<0.001).
Early complications are shown in Table 5 . Immediate postsphincterotomy bleeding was observed in 1.8% (2/109) of group A and in 3.6% (7/197) of group B (p=0.394). The
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rate of delayed bleeding was 0% in group A and 1.0% (2/ 197) in group B. All of these 9 cases were successfully treated by HSE injection. Post-ERCP pancreatitis occurred in 3.7% (6/164: all mild) in group A, and 3.0% (8/264: mild 7, moderate 1) in group B (p=0.712). No patient in either group experienced duodenal perforation. Only one patient in group B developed aspiration pneumonia, which was treated conservatively with antibiotics. Neither mental deterioration nor mortality was observed in the two groups.
Eighty-nine out of 118 patients in group A (75%) and 161 out of 205 patients in group B (79%) were followed up for more than 3 months. The ratios of followed-up patients in the two groups were comparable (p=0.419). There was no significant difference in the cumulative cholangitis-free period after the first endoscopic treatment between the two groups (Fig. 1) . The prognoses of the 241 patients with complete stone clearance and the 9 patients with permanent plastic stent placement were also analyzed (Fig. 2) . One out of 9 patients with stenting required stent exchange during the follow-up period. In the short term, the cumulative cholangitis-free period was comparable.
Discussion
ERCP is an established diagnostic and therapeutic tool for pancreatobiliary diseases including choledocholithiasis. There have been several reports on the results of therapeutic ERCP for the elderly. The rate of technical success, complete duct clearance, early/late complications, and mortality are reportedly 80.5%-100%, 86.0%-98.0%, 5.0%-6.3%/0-5.0%, and 0-3.2%, respectively (11) (12) (13) (14) . Our results were in concordance with these figures.
In the present study, EST was performed in most cases to facilitate stone extraction, and EPBD was chosen in a small number of cases. Our therapeutic strategy is based on the previous report that post-ERCP pancreatitis occurs more frequently after EPBD than EST (16) . A systematic review (17) has also shown that EPBD carries a higher risk of pancreatitis. Asian trials (18-21) which comprised older participants (mean age greater than 60 years) showed no significantly increased risk of pancreatitis and significantly lower bleeding rate in EPBD cases. Therefore, elderly patients, especially those under anticoagulant therapy, may benefit from EPBD.
The complete duct clearance rate was significantly lower in group A, and biliary stent placement was performed in which complete duct clearance was not achieved primarily due to the poor general condition of patients. Sugiyama and Atomi (11) also reported that the rate of duct clearance was lower, although not significantly, in patients aged 90 years or older than those 70 to 89 years of age (86% vs 95%). In the present study, the short-term prognosis in biliary stent placement cases was satisfactory. Only 1 out of 9 cases (11%) experienced recurrence of cholangitis during a median follow-up period of 785 days. In this case, multiple stones including large cystic duct stones were visualized by cholangiography in the extrahepatic bile duct, and complete stone clearance could not be achieved. On the other hand, a randomized study (7) comparing endoscopic biliary endoprosthesis and complete duct clearance in high-risk patients has shown similar early complication rates and significantly higher long-term biliary complication rate in the former. Bergman et al (8) reported that complications, mainly cholangitis, were observed in 40% of elderly patients who had undergone permanent biliary stent placement during a median follow-up period of 36 months. Therefore, although we need more well-designed randomized controlled trials to draw a conclusion on this issue, complete stone clearance is deemed preferable. Permanent biliary stent placement could be an alternative at least for short time period for patients in poor general condition. If general condition of patients permits, periodical stent exchange seems desirable. Although the optimal exchange interval has not been established, annual exchange may be acceptable because Ang et al (22) reported in their review article that the mean duration of stent patency was 12.4 months. Our results support this interval. Further studies are necessary concerning the costeffectiveness and safety of endoscopic treatment in the elderly.
Appropriate sedation is indispensable for the success of endoscopic procedures. However, oxygen desaturation or hypotension caused by sedative agents is a matter of concern. Muller et al (23) reported that ages >60 years and ASA score III are predictive factors of oxygen desaturation during ERCP. Therefore, more attention should be paid to vital signs in the elderly than in younger patients during ERCP after administration of sedatives. In the present study, cooperation of patients was significantly worse in group A, while there was no significant difference in the rate of cardiorespiratory suppression between the two groups. The fact that the total amount of sedative agents administered was less in group A is a possible explanation for this. The elderly are liable to show susceptibility to adverse effects of drugs, which may have affected the determination of the dosage by the endoscopist. Senile dementia might be an another contributing factor. Further investigation is necessary to establish an optimal method and dosage of sadation for the elderly.
There are several limitations of this study. Because of its retrospective nature, information on the cases excluded from therapeutic ERCP was not available. It is probable that elderly patients with severe comorbidities are at greater risk of developing complications, while there are no established indications for endoscopic procedures in the elderly. From the present study, the PS of a patient does not seem to influence the complication rate. ASA class might be a predisposing factor of complications. In this study, most patients were ASA class I-III. Therefore, safety and efficacy of therapeutic ERCP for patients of ASA class IV or V, especially in an emergent situation, cannot be discussed. Those with ASA class IV or V are in a critical condition, and an increased risk of complications is expected during/after treatments. Unfortunately, the safety of therapeutic ERCP in the elderly, with ASA class IV or V has not been well-documented. Further accumulation of cases is necessary to reach a consensus on this issue.
Another limitation is the relatively low follow-up rate because of difficulty in periodical follow-up as a referral center. The follow-up term was also still short. However, the follow-up rate was comparable between the two groups, and there was no significant difference in the recurrence rate of acute cholangitis in followed-up cases.
In conclusion, with a duct clearance rate of more than 90% and plastic stent placement for patients with poor general condition, therapeutic ERCP for choledocholithiasis in patients 80 years of age or older is comparable in safety and effectiveness to that in younger patients.
